Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Megacap 300 Growth Index ETF Vanguard | MGK | Nov 1, 2024 | 322.62 | +0.85 |
Megacap 300 Index ETF Vanguard | MGC | Nov 1, 2024 | 205.93 | +0.61 |
Megacap 300 Value Index ETF Vanguard | MGV | Nov 1, 2024 | 126.64 | +0.09 |
MEI Pharma | MEIP | Nov 1, 2024 | 3.07 | -0.97 |
Meihua International Medical Technologies | MHUA | Nov 1, 2024 | 0.68 | -0.25 |
MeiraGTx Holdings | MGTX | Nov 1, 2024 | 5.81 | +4.87 |
Meiwu Technology | WNW | Nov 1, 2024 | 0.78 | +1.29 |
Melar Acquisition I | MACI | Nov 1, 2024 | 10.04 | 0.00 |
Melar Acquisition I | MACIU | Nov 1, 2024 | 10.13 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Nov 1, 2024 | 6.72 | 0.00 |
MercadoLibre | MELI | Nov 1, 2024 | 2 054.90 | +0.87 |
Mercantile Bank | MBWM | Nov 1, 2024 | 43.21 | +0.82 |
Mercer International | MERC | Nov 1, 2024 | 6.44 | -1.23 |
Merchants Bancorp | MBIN | Nov 1, 2024 | 36.32 | -1.68 |
Merchants Bancorp B | MBINO | Nov 1, 2024 | 25.21 | -0.03 |
Merchants Bancorp C Pref | MBINN | Nov 1, 2024 | 22.65 | -1.52 |
Merchants Bancorp Pref D | MBINM | Nov 1, 2024 | 25.72 | -0.12 |
Merck & Co | MRK | Nov 1, 2024 | 101.88 | -0.43 |
Mercurity Fintech | MFH | Nov 1, 2024 | 1.21 | +7.08 |
Mercury General | MCY | Nov 1, 2024 | 65.61 | -2.99 |
Mercury Systems | MRCY | Nov 1, 2024 | 33.18 | +2.57 |
Mereo BioPharma ADR | MREO | Nov 1, 2024 | 4.28 | +1.66 |
Meridian | MRBK | Nov 1, 2024 | 13.84 | -1.42 |
MeridianLink | MLNK | Nov 1, 2024 | 22.21 | +1.14 |
Merit Medical Systems | MMSI | Nov 1, 2024 | 98.80 | +0.14 |
Meritage Homes | MTH | Nov 1, 2024 | 183.44 | +1.24 |
Merrill Lynch & Co. | IPB | Nov 1, 2024 | 26.68 | +0.68 |
Mersana Therapeutics | MRSN | Nov 1, 2024 | 1.82 | +0.55 |
Merus N.V | MRUS | Nov 1, 2024 | 50.30 | +0.74 |
Mesa Air Group | MESA | Nov 1, 2024 | 0.92 | +0.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.